Molecular Mimicry between Respiratory Syncytial Virus F Antigen and the Human Proteome

Molecular Mimicry between Respiratory Syncytial Virus F Antigen and the Human Proteome

This study examined respiratory syncytial virus (RSV) F glycoprotein (gp) antigen for molecular mimicry with the human proteome. It was found that the viral antigen presents an impressive number of pentapeptides (namely, 525 out of 570) in common with the human proteome, with viral sequences widely...

Full description

Bibliographic Details
Main Author:	Darja Kanduc
Format:	Article
Language:	English
Published:	Georg Thieme Verlag KG 2023-01-01
Series:	Global Medical Genetics
Subjects:	molecular mimicry rsv f anti-rsv vaccines
Online Access:	http://www.thieme-connect.de/DOI/DOI?10.1055/s-0043-1761489

Similar Items

Respiratory Syncytial Virus Prevention through Monoclonal Antibodies: A Cross-Sectional Study on Knowledge, Attitudes, and Practices of Italian Pediatricians
by: Matteo Riccò, et al.
Published: (2023-02-01)

All Eyes on the Prefusion-Stabilized F Construct, but Are We Missing the Potential of Alternative Targets for Respiratory Syncytial Virus Vaccine Design?
by: Sofie Schaerlaekens, et al.
Published: (2024-01-01)

Protective antigenic sites identified in respiratory syncytial virus fusion protein reveals importance of p27 domain
by: Jeehyun Lee, et al.
Published: (2022-01-01)

Current State and Challenges in Developing Respiratory Syncytial Virus Vaccines
by: Carlotta Biagi, et al.
Published: (2020-11-01)

Epidemiology and prevention of respiratory syncytial virus infections in children in Italy
by: Chiara Azzari, et al.
Published: (2021-10-01)

Epidemiology and molecular characteristics of respiratory syncytial virus (RSV) among italian community-dwelling adults, 2021/22 season
by: Donatella Panatto, et al.
Published: (2023-03-01)

Level of maternal respiratory syncytial virus (RSV) F antibodies in hospitalized children and correlates of protection
by: Sara A. Taleb, et al.
Published: (2021-08-01)

Human Respiratory Syncytial Virus Epidemiological Burden in Pediatric Outpatients in Italy: A Systematic Review
by: Sara Boccalini, et al.
Published: (2023-09-01)

Respiratory Syncytial Virus Entry Inhibitors Targeting the F Protein
by: Shibo Jiang, et al.
Published: (2013-01-01)

Synthetic Biodegradable Microparticle and Nanoparticle Vaccines against the Respiratory Syncytial Virus
by: Patricia A. Jorquera, et al.
Published: (2016-12-01)

New Insights on Respiratory Syncytial Virus Prevention
by: Edyta Kopera, et al.
Published: (2023-11-01)

Mutation of Respiratory Syncytial Virus G Protein’s CX3C Motif Attenuates Infection in Cotton Rats and Primary Human Airway Epithelial Cells
by: Binh Ha, et al.
Published: (2019-07-01)

The Quest for a Respiratory Syncytial Virus Vaccine for Older Adults: Thinking beyond the F Protein
by: Victoria A. Jenkins, et al.
Published: (2023-02-01)

Respiratory Syncytial Virus Matrix Protein Is Sufficient and Necessary to Remodel Host Mitochondria in Infection
by: MengJie Hu, et al.
Published: (2023-05-01)

Bivalent vaccines effectively protect mice against influenza A and respiratory syncytial viruses
by: Sathya N. Thulasi Raman, et al.
Published: (2023-12-01)

Unveiling Integrated Functional Pathways Leading to Enhanced Respiratory Disease Associated With Inactivated Respiratory Syncytial Viral Vaccine
by: Marsha S. Russell, et al.
Published: (2019-03-01)

Burden of respiratory syncytial virus infections in China: Systematic review and meta–analysis
by: Yaowen Zhang, et al.
Published: (2015-12-01)

Role of Respiratory Syncytial Virus in Pediatric Pneumonia
by: Sonia Bianchini, et al.
Published: (2020-12-01)

Original Antigenic Sin and Respiratory Syncytial Virus Vaccines
by: Ralph A. Tripp, et al.
Published: (2019-09-01)

Epidemiology and molecular analyses of respiratory syncytial virus in the 2021–2022 season in northern Italy
by: Alessia Lai, et al.
Published: (2024-01-01)

Non-Coding RNAs and Their Role in Respiratory Syncytial Virus (RSV) and Human Metapneumovirus (hMPV) Infections
by: Wenzhe Wu, et al.
Published: (2020-03-01)

Human respiratory syncytial virus and coronavirus rates in Iranian elderly patients more than 60 years old with acute respiratory symptoms
by: Shaian Tavakolian, et al.
Published: (2023-01-01)

Fc-mediated functions of nirsevimab complement direct respiratory syncytial virus neutralization but are not required for optimal prophylactic protection
by: Tyler Brady, et al.
Published: (2023-10-01)

Early-Life Lung and Gut Microbiota Development and Respiratory Syncytial Virus Infection
by: Kazuma Yagi, et al.
Published: (2022-04-01)

The Influence of COVID-19 on Influenza and Respiratory Syncytial Virus Activities
by: Pritish Mondal, et al.
Published: (2022-02-01)

Reducing respiratory syncytial virus (RSV) hospitalization in a lower-income country by vaccinating mothers-to-be and their households
by: Samuel PC Brand, et al.
Published: (2020-03-01)

Assessing the patient experience of respiratory syncytial virus infection: development of a patient-reported outcome measure
by: Carla (DeMuro) Romano, et al.
Published: (2023-02-01)

Simultaneous Administration of Recombinant Measles Viruses Expressing Respiratory Syncytial Virus Fusion (F) and Nucleo (N) Proteins Induced Humoral and Cellular Immune Responses in Cotton Rats
by: Yoshiaki Yamaji, et al.
Published: (2019-03-01)

Molecular Epidemiology and Genetic Diversity of Human Respiratory Syncytial Virus in Sicily during Pre- and Post-COVID-19 Surveillance Seasons
by: Fabio Tramuto, et al.
Published: (2023-08-01)

Relationship between neighborhood census-tract level socioeconomic status and respiratory syncytial virus-associated hospitalizations in U.S. adults, 2015–2017
by: Jenna E. Holmen, et al.
Published: (2021-03-01)

High seroprevalence of antibodies against human respiratory syncytial virus and evidence of respiratory syncytial virus reinfection in young children in Thailand
by: Siripat Pasittungkul, et al.
Published: (2022-12-01)

Back to the future of viruses: a case of triple coinfection caused by respiratory syncytial virus, human coronavirus OC43, and rhinovirus
by: Benjamin Davido, et al.
Published: (2023-05-01)

Psychometric evaluation of the respiratory syncytial virus infection, intensity and impact questionnaire (RSV-iiiQ) in adults
by: Valerie Williams, et al.
Published: (2024-02-01)

The potential public health impact of the respiratory syncytial virus prefusion F protein vaccine in people aged ≥60 years in Japan: results of a Markov model analysis
by: Daisuke Kurai, et al.
Published: (2024-12-01)

RSV disease in infants and young children: Can we see a brighter future?
by: Eugenio Baraldi, et al.
Published: (2022-11-01)

Prevention and Potential Treatment Strategies for Respiratory Syncytial Virus
by: Bo-Wen Sun, et al.
Published: (2024-01-01)

Respiratory syncytial virus subtypes in children with bronchiolitis: does it correlate with clinical severity?
by: Shuo Yang, et al.
Published: (2024-02-01)

Prognosis of Laboratory-Confirmed Influenza and Respiratory Syncytial Virus in Acute Heart Failure
by: David Carballo, et al.
Published: (2021-09-01)

The respiratory syncytial virus (RSV) prefusion F‐protein functional antibody repertoire in adult healthy donors
by: Emanuele Andreano, et al.
Published: (2021-06-01)

Evaluation of luciferase and prefusion-stabilized F protein from respiratory syncytial virus mRNA/LNPs in pre-clinical models using jet delivery compared to needle and syringe
by: Brian K. Meyer, et al.
Published: (2024-01-01)